CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Mupirocin (drug) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07064161
NCT07064161N/ACompleted

A Double-Blind Randomized Controlled Trial on the Efficacy of Hydrocolloid Dressing vs. Topical Antibiotic on Wound Healing of Post-Punch Biopsy Wounds Among Patients in a Tertiary Hospital in Manila

University of Santo Tomas Hospital, Philippines·interventional·Posted Jul 14, 2025·Updated Aug 24, 2025

In Brief

A clinical study evaluating Mupirocin (drug) and Hydrocolloid Dressing (DuoDERM CGF) for Biopsy Wound. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The main objective of this study is to determine the efficacy of using hydrocolloid dressing on wound healing of post-punch biopsy wounds vs topical antibiotic. Specifically, it aims to measure the following parameters: the presence or absence of infection, the clinical estimate of reepithelialization, the clinical estimate of wound closure, scar formation, pigmentation of scar, and the cosmetic appearance of the wound. The study is a double-blind randomized controlled trial which will be conducted at the Dermatology outpatient department and the private clinics of dermatology consultants of the University of Santo Tomas Hospital. Patients who will be included are those who are 18 to 64 years of age with clean cutaneous lesions. Excluded from this study are those who have infected wounds, those who have conditions with poor tendency to heal including diabetes mellitus, peripheral vascular disease, history of keloid formation, those currently receiving anticoagulation therapy or systemic corticosteroids, and those known to have hypersensitivity to topical antibiotics. The primary outcome measure is the proportion of patients who achieved better overall healing when treated with hydrocolloid dressing.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBiopsy Wound
CountriesPhilippines
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedJul 14, 2025
Enrollment StartJan 29, 2024
Primary CompletionOct 7, 2024
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 12 months ago

Interventions

Mupirocin (drug)drug

Wounds were dressed with gauze impregnated with mupirocin ointment covered by a transparent dressing (Tegaderm)

Hydrocolloid Dressing (DuoDERM CGF)drug

Wounds were dressed with a 1-inch size Duoderm Control Gel Formula hydrocolloid dressing